A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of LasoperinTM on Cognitive Function in Healthy Adults

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 3, 2022

Primary Completion Date

October 18, 2022

Study Completion Date

October 18, 2022

Conditions
Cognitive ImpairmentCognitive DeclineCognition Disorders in Old AgeWell-Being, PsychologicalInflammationCognitive Fun
Interventions
DIETARY_SUPPLEMENT

LasoperinTM

"Active ingredients:~Scutellaria baicalensis extract, 240 mg per capsule. Acacia catechu extract, 51 mg per capsule. With no less than 180 mg of baicalin, and no less than 30 mg of catechins from the above-mentioned extracts per capsule.~Inactive ingredients:~Maltodextrin"

DIETARY_SUPPLEMENT

Placeo

"Active ingredients:~N/A~Inactive ingredients:~Microcrystalline cellulose"

Trial Locations (1)

63301

Exercise and Performance Nutrition Laboratory, Saint Charles

All Listed Sponsors
lead

Lindenwood University

OTHER